IIT Madras and Unicorn India Ventures Announce First Close of ₹450 Cr Deeptech Fund

A Milestone for Academic-VC Partnerships

IIT Madras, along with the IIT Madras Research Park (IITMRP) and early-stage venture capital firm Unicorn India Ventures, has announced the first close of their dedicated deeptech fund at ₹450 Cr. This collaborative initiative marks a significant shift in the Indian startup ecosystem, focusing specifically on the commercialization of high-tech research and intellectual property originating from one of the country’s premier engineering institutions. The fund aims to provide critical capital to startups that are often considered too risky for traditional early-stage investors due to their long development cycles and high technical complexity.

Strategic Focus on Deeptech and Hardware

The fund is strategically positioned to support startups working in sectors such as space technology, robotics, advanced materials, and sustainable energy. By leveraging the technical expertise of the IIT Madras faculty and the operational experience of Unicorn India Ventures, the fund seeks to offer more than just capital. Portfolio companies will gain access to the state-of-the-art facilities at the IIT Madras Research Park, mentorship from industry veterans, and a global network of alumni and corporate partners. This multifaceted support system is designed to reduce the time-to-market for complex hardware and software solutions that address global challenges.

Strengthening the Indian Innovation Pipeline

The successful first close at ₹450 Cr reflects a growing confidence among domestic and institutional investors in the potential of Indian deeptech. For founders, this fund represents a dedicated source of patient capital that understands the nuances of academic-led innovation. For the broader ecosystem, it sets a precedent for how universities and venture capital firms can collaborate to build a robust pipeline of high-value startups. As the fund moves toward its final close, the partnership intends to focus on early-stage investments, typically targeting the seed to Series A rounds, ensuring that breakthrough research doesn't stall at the prototype stage due to lack of funding.